On Saturday, Pfizer Inc (NYSE: PFE) presented positive trial data for experimental drug designed for patients suffering from cancer cachexia during the European Society for Medical Oncology 2024 ...

马萨诸塞州剑桥市 - mRNA疗法和疫苗领域的先驱Moderna Inc (NASDAQ:MRNA)今日宣布，前Vifor Pharma首席执行官和葛兰素史克制药和疫苗全球总裁Abbas Hussain已被任命为公司董事会成员。

The CNBC host said that he has reminded his viewers repeatedly that when the Fed is your “enemy” you should stick to ...

马萨诸塞州剑桥市 - Moderna Inc (NASDAQ:MRNA) 已启动其诺如病毒疫苗候选物的3期临床试验，这标志着解决该病毒所带来的广泛公共卫生问题迈出了重要一步。今天，美国第一位参与者接受了疫苗候选物mRNA-1403的剂量，作为Nova ...

Cartesian Therapeutics is a clinical-stage company developing mRNA cell therapies for the treatment of autoimmune diseases. The Company’s lead asset, Descartes-08, is an mRNA CAR-T in Phase 2b ...

CAMBRIDGE, MA and TAIPEI, TAIWAN / ACCESSWIRE / September 30, 2024 / Moderna, Inc. (Nasdaq:MRNA) and Cenra Healthcare, the sales and marketing ...

Shares of NASDAQ MRNA opened at $68.28 on Friday. The stock has a market cap of $26.17 billion, a P/E ratio of -4.36 and a beta of 1.67. Moderna has a twelve month low of $62.55 and a twelve month ...

Shares of NASDAQ:MRNA traded up $0.58 during trading on Thursday, hitting $70.44. 261,637 shares of the company were exchanged, compared to its average volume of 4,233,954. The business’s 50 day ...

Hussain brings more than 35 years of commercial leadership and operating experience in healthcare, most recently serving as CEO of Vifor Pharma ...

Pfizer Inc (NYSE: PFE) made a promise to outdo cancer, joining its Covid vaccine-peer, Moderna Inc (NASDAQ: MRNA) in turning ...

Moderna Inc (NASDAQ:MRNA)上升4.08%，收盘价为71.99。 表现最差的个股Deckers Outdoor Corp. (NYSE:DECK)最终跌83.46%，尾盘收于155.10；埃森哲 (NYSE:ACN)跌幅为4.82% ...